Survey Shows Wide Variation in How Pain Physicians Handle Blood Thinners Before Procedures

Survey Shows Wide Variation in How Pain Physicians Handle Blood Thinners Before Procedures

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published April 29, 2025 | Category: Pain Medicine

Stopping blood thinners before a pain procedure lowers bleeding risk but can raise the risk of stroke, heart attack and blood clots. A 2024 study in Pain Physician surveyed U.S. interventional pain physicians about their current practices and compared them with a similar survey from 2012.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

In October 2021, the American Society of Interventional Pain Physicians (ASIPP) sent an online survey to 1,700 members, and 185 completed it. The questions mirrored the 2012 survey and asked how physicians manage aspirin, other antiplatelet drugs and anticoagulants before low-, moderate- and high-risk procedures.

What they found

  • 23% of physicians had changed their practice in the previous year.
  • All physicians stopped warfarin, and most accepted an INR of 1.5 as safe.
  • Low-dose aspirin was stopped by 8% of physicians for low-risk procedures, 34% for intermediate-risk procedures and 76% for high-risk procedures.
  • Clopidogrel and similar drugs were stopped by roughly 26% to 41% for low-risk procedures, almost 90% for intermediate-risk procedures and over 97% for high-risk procedures.
  • Newer anticoagulants (apixaban, rivaroxaban, edoxaban and dabigatran) were stopped by about 25% to 33% for low-risk procedures, about 90% for intermediate-risk procedures and 99% for high-risk procedures.

The authors note a continued pattern of stopping these medications around procedures.

Why this matters

Practice varies widely, especially for low-risk procedures, where stopping blood thinners may expose patients to clotting risks without clear benefit. Shared decisions with the prescribing physician and use of current guidelines can help balance bleeding and clotting risks.

Limitations

Only 11.6% of members responded, the survey covered one organization in one country, and actual bleeding or clotting events were not measured.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Classify each procedure's bleeding risk, and follow current society guidelines on blood thinners.
  • Consult the prescribing cardiologist or physician before stopping anticoagulants or antiplatelet drugs, especially after recent stents or clots.
  • Give patients clear written instructions on when to stop and restart.

For hospitals, clinics and safety leaders

  • Standardize blood thinner protocols for pain procedures based on current guidelines.

For patients and families

  • Never stop a blood thinner on your own. Ask your physicians for a coordinated plan.

Reference

  1. Manchikanti L, Sanapati MR, Pampati V, Soin A, Hirsch JA. Updated Assessment of Practice Patterns of Perioperative Management of Antiplatelet and Anticoagulant Therapy in Interventional Pain Management. Pain Physician. 2024 Aug;27(S6):S95-S114. PMID: 39133737. PubMed: https://pubmed.ncbi.nlm.nih.gov/39133737/

This article is educational information, not legal or medical advice.

Previous
Previous

Ultrasound Probe Disinfection: Guidelines Agree on Covers and Sterile Gel, Not on Disinfection Level

Next
Next

Non-Particulate Steroid Performed at Least as Well as Particulate Steroid in Lumbar Transforaminal Injections